Information Management Services, Inc.

Information Management Services, Inc., doing business as IMS, is a Maryland-based for-profit Subchapter S corporation that provides biomedical data management, computing infrastructure, analytics, IT systems support, and software development services to federal health research agencies as a prime contractor on 98% of its recent awards. IMS operates primarily in full-and-open competition without set-aside designations, though the vendor holds positions on small-business-reserved vehicles including the CIO-SP3 Small Business GWAC and carries Total Small Business set-aside task orders on select contracts.

IMS's customer concentration is heavily skewed toward the National Institutes of Health. The top five customer agencies account for 75% of awards by count, with the National Cancer Institute dominating both volume and dollar value at 109 awards carrying $3.12 billion in combined potential value — nearly 87 times the vendor's combined potential value across all other customers. Within NCI, IMS holds a $147 million multiple-award IDIQ for biomedical computing research and development services awarded September 2026, supporting the Division of Cancer Epidemiology and Genetics across data modeling, statistical programming, bioinformatics, and tool development. The National Heart Lung and Blood Institute (23 awards, $46.8 million combined potential value) and the National Institute of Child Health and Human Development (5 awards, $81.1 million potential value) represent secondary concentrations. The National Institutes of Health broadly (57 awards) and the CDC Pittsburgh (7 awards, $41.9 million) round out the active customer set. Across the portfolio, 28 distinct federal agencies have placed awards, but NCI and other NIH institutes account for the overwhelming majority of both transaction volume and dollars.

IMS's capability footprint centers on biomedical data systems and research infrastructure. Representative recent prime work includes a $21.74 million NCI delivery order (September 2026) under GSA Multiple Award Schedule for data management, computer programming, computing infrastructure services, website development, and systems design and development support for the Division of Cancer Prevention, running through April 2031 on time-and-materials pricing; an $84.4 million delivery order (June 2025) against the NITAAC CIO-SP3 Small Business IDIQ for biomedical computing support services, priced on a cost-plus-fixed-fee basis through December 2029; a $29.1 million delivery order (March 2025) under the Biomedical Information Management and Analytic Support Services indefinite delivery contract for data modeling, acquisition and management, data analytics including statistical programming and bioinformatics, and tool and software development, running through January 2030; and a $13.5 million CDC delivery order (June 2024) under CIO-SP3 Small Business for data management and technical assistance supporting the Division of Cancer Prevention and Control, extending through July 2029. Smaller work includes a $1.956 million National Institute for Minority Health and Health Disparities delivery order for HDPULSE data portal and interventions IT support (September 2025), a $1.624 million National Heart Lung and Blood Institute delivery order for BioLINCC Program enhancement (November 2025), and maintenance and support orders for biospecimen inventory systems (BSI software) across multiple NIH institutes, CDC, and FDA. GSA Multiple Award Schedule represents IMS's primary vehicle for smaller orders, with 32 task orders carrying $192.1 million in combined potential value; other major vehicles include the Indefinite Delivery Contract HHSN261201100007I (27 task orders, $103.6 million), the Blanket Purchase Agreement HHSN261201500002B (22 task orders, $44.5 million), and the Indefinite Delivery Contract HHSN261201300008I (14 task orders, $33 million).

IMS's capability portfolio, grounded in SCI-reportable federal service contracts, reflects strong biomedical research data systems expertise. On federal services contracts above the $150,000 SCI reporting threshold, government-paid hourly rates range from $52.50/hr at the tenth percentile to $139.01/hr at the ninetieth percentile, with a median of $85.98/hr. GSA Schedule labor categories span administrative associate ($64.97/hr), network administrator ($91.16/hr), programmer/analyst ($102.69/hr), systems analyst ($141.46/hr), and program manager ($244.15/hr), reflecting a blend of support, technical, and senior delivery roles. The SCI dataset shows a stable workforce delivering federal services contracts: IMS reported 161 FTEs in FY2022 declining to 154 FTEs in FY2025 across 156–166 full-time equivalents over the four-year window. SCI-reported invoiced revenue declined from $37.9 million in FY2022 to $22.5 million in FY2025, reflecting either contract completion, reduced task order volume, or both; however, this represents only a subset of IMS's total federal work, as the portfolio's combined potential value of $23.89 billion vastly exceeds SCI-captured dollars. Across the SCI-reportable prime contracts, IMS self-performed substantially all contractor hours with zero average subcontractor share, indicating a direct-delivery, in-house labor model.

IMS operates as a subcontractor on a small slice of recent work (2% of awards), subcontracting to Sarstedt Inc. on a CDC SEER surveillance project (August 2025), to Panamerica Computers Inc. on NCI COVID-19 research data infrastructure work (January 2025), to IT1 Source LLC on serological sciences statistical support (November 2023), and to The Henry M. Jackson Foundation on trials and studies in support of medical countermeasure development and COVID response (November 2022). This sub-work represents opportunistic extensions of the vendor's biomedical research data and analytics capabilities under larger primes rather than a core go-to-market model.

Recent activity shows volatility: 14 awards in 2022, declining to 5 in both 2024 and 2026, with 9 awards in 2025 — suggesting either reporting lag, selective capture of major awards in the source data, or irregular award timing around large IDIQ and BPA vehicles. Fourteen awards with combined potential value of $78.7 million face ultimate completion within the next twenty-four months, creating immediate recompete exposure for the vendor and opportunity for competitors on major renewal rounds, particularly for NCI data management and analytics work and CDC cancer prevention support.

IMS specializes in customized applications development, LAN support, UNIX workstation support, statistical programming and generalized computing services. Our primary field of support is biomedical research.